PlainPharmaWatch

CMS Open Payments · Program Year 2024

Fresenius USA Inc.

Fresenius USA Inc. reported $256.00 across General Payments, Research, and Ownership to 1 physicians and teaching hospitals across 1 transactions.

See the rankings → How this is sourced
$256.00
All-tracks total
1
Transactions
1
Recipients
#1895
of 1,925 companies

Fresenius USA Inc. reported $256.00 across all CMS Open Payments tracks (General + Research + Ownership) to 1 physicians and teaching hospitals in Program Year 2024 - ranking #1895 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $256.00, averaging $256.00 per recipient.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the publisher.

CMS Sunshine Act warrant

Manufacturer fresenius-usa-inc Fresenius USA Inc.

$256.00 · #1895/1,925 · 0.0% industry · PY2024

  • TOT $256.00
  • RANK #1895
  • SHARE 0.0%
  • TXN 1
  • RCP 1
  • CAT 1
  • GEN $256.00
  • TOP1 100.0%
  • PY 2024

Volume peers

Nearest volume peer: Voximetry, Inc. ($255.65)

AmerisourceBergen Drug Corpo…$268.97PARI Respiratory Equipment, …$262.70Fresenius USA Inc. (this)$256.00Voximetry, Inc.$255.65Angelus Industria de Produto…$250.00
All-tracks payment totals near Fresenius USA Inc. (CMS Open Payments PY2024)

Fresenius USA Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →

What the Data Shows for Fresenius USA Inc.

$256.00: that is what Fresenius USA Inc. reported in payments to 1 physicians and teaching hospitals during Program Year 2024, spread across 1 transactions ($256.00 per transaction, $256.00 per recipient). The company sits at rank #1895 of 1,925, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.

1 transactions worth $256.00 make "Consulting Fee" the top general-payment category in the 1-category breakdown below, 100.0% of General Payments (see our methodology for how research and ownership payments are reported separately).

General Payment Breakdown by Type

Fresenius USA Inc. made 1 types of general payments. "Consulting Fee" is the largest category at $256.00, 100.0% of General Payments.

How Fresenius USA Inc. divides its payments

How the reported total splits across payment categories

1. Consulting Fee$256.00
Payment Type Amount Transactions
Consulting Fee $256.00 1

Recipient Concentration in General Payments

The five largest recipient relationships account for $256.00 (100.0%) of $256.00 in this company's General Payments records across 1 recipients.

General Payments scope note

Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Fresenius USA Inc.

The five named recipients with the highest reported General Payments from this company

Ucsf Medical Center$256.00
  1. 1

    Ucsf Medical Center

    $256.00 across 1 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Similarly Concentrated Companies

Companies whose General Payments are spread across recipients about as (un)evenly as Fresenius USA Inc.'s, measured by the same HHI concentration index above, not by payment size.

What HHI 2,500 means here

2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Fresenius USA Inc..

b2d Marketing

HHI 10000

PFM Medical, Inc.

HHI 10000

Mohawk Hospital Equipment, Inc.

HHI 10000

Konan Medical USA, Inc.

HHI 10000

Companies with Similar Payment Volumes

Open a profile or compare a similar company's CMS-reported payment pattern with Fresenius USA Inc..

Showing 6 of 1,924 companies with CMS-reported payment data.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Fresenius USA Inc.'s data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.